MedPath

Clinical Values of Mature Fistulas in Hemodialysis

Conditions
Hemodialysis Complication
Hemodialysis Access Failure
Interventions
Procedure: AVF puncture
Registration Number
NCT04416971
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

The arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis(HD), and fistula-first is the general recommendation for all HD patients. But in clinical practice in China, quite a few patients start HD before AVF maturation due to various situations. Whether HD initiation with mature AVF will influence the patency and complications is controversial. This study is aim to compare the AVF patency in incident HD patients with mature or immature AVF on HD initiation, and to compare other clinical outcomes, including abandonment without use, infection, and other AVF complications occurrence.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • underwent initial upper-extremity AVF creation for incident HD at Zhongshan Hospital, Fudan University
Exclusion Criteria
  • with malignancies
  • not followed-up at Zhongshan Hospital, Fudan University

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
immature AVFAVF puncturePatients initiate HD with immature AVF.
mature AVFAVF puncturePatients initiate HD with mature AVF.
Primary Outcome Measures
NameTimeMethod
AVF patencyJune 2020 to June 2021

A functional AVF was defined as allowing at least six adequate HD sessions without any AVF-related complications. Primary AVF patency was defined as the interval from HD initiation via a functional AVF to any intervention designed for maintenance or reestablishment of AVF function, AVF failure, or study end, whichever occurred first, and secondary AVF patency was defined as the interval from HD initiation via an AVF until the termination of HD via AVF due to any cause, regardless of the number of subsequent interventions.

Secondary Outcome Measures
NameTimeMethod
Abandonment without use, infection, and other complications of AVF creation.June 2020 to June 2021

Abandonment without use, infection, and other complications of AVF creation.

Trial Locations

Locations (1)

No.180, Fenglin Road, Xuhui District

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath